Mon, September 14, 2009
Fri, September 11, 2009
Thu, September 10, 2009
Wed, September 9, 2009
Tue, September 8, 2009
Sun, September 6, 2009
Fri, September 4, 2009
Thu, September 3, 2009
Wed, September 2, 2009
Tue, September 1, 2009
Mon, August 31, 2009
Fri, August 28, 2009
Thu, August 27, 2009
Wed, August 26, 2009
Tue, August 25, 2009
Mon, August 24, 2009
Sun, August 23, 2009
Fri, August 21, 2009
Thu, August 20, 2009
Wed, August 19, 2009
Tue, August 18, 2009
Mon, August 17, 2009
Sun, August 16, 2009
Fri, August 14, 2009
Thu, August 13, 2009
Wed, August 12, 2009
Tue, August 11, 2009
Mon, August 10, 2009
Fri, August 7, 2009
Thu, August 6, 2009
Wed, August 5, 2009
Tue, August 4, 2009
Mon, August 3, 2009
Sat, August 1, 2009
Fri, July 31, 2009
Thu, July 30, 2009
Wed, July 29, 2009
Tue, July 28, 2009
Mon, July 27, 2009
Sat, July 25, 2009
Fri, July 24, 2009
Thu, July 23, 2009
Wed, July 22, 2009
Tue, July 21, 2009

Lpath, Inc.: Lpath to Present at the Southern California Investor Conference


//health-fitness.news-articles.net/content/2009/ .. the-southern-california-investor-conference.html
Published in Health and Fitness on Friday, August 14th 2009 at 5:41 GMT, Last Modified on 2009-08-14 05:41:38 by Market Wire   Print publication without navigation


SAN DIEGO, CA--(Marketwire - August 14, 2009) - Lpath, Inc. (OTCBB: [ LPTN ]), the category leader in therapeutic agents against bioactive lipids, will present at the 14th Annual Southern California Investor Conference being held on August 18, 2009 at the Island Hotel in Newport Beach, California.

The conference is hosted by California Equity Research and highlights the abundance of growth companies located in the region, including world-recognized life science, technology, media, and real estate/financial companies.

Lpath President and CEO Scott R. Pancoast is scheduled to present on Tuesday, August 18 at 9:30 a.m. Pacific time (12:30 p.m. Eastern time), followed by a break-out session and one-on-one meetings. The presentation will be available via webcast at [ http://events.powerstream.net/002/00271/20090818SCIC-T3/ ].

For more information on the Southern California Investor Conference, please visit the conference website at [ www.californiastocks.com ] or call the conference desk at (858) 829-8688.

About Lpath

San Diego-based Lpath, Inc. is the category leader in lipidomics-based therapeutics, an emerging field of medicine that targets bioactive signaling lipids for treating a wide range of human disease. Lpath's ImmuneY2™ drug-discovery engine has the unique ability to generate therapeutic antibodies that bind to and inhibit bioactive lipids that contribute to disease. The company is currently advancing three drug candidates, two of which -- ASONEP™ for cancer and iSONEP™ for AMD -- are in late-Phase 1 clinical trials, For ASONEP, Lpath has joined with international drug giant Merck-Serono under a worldwide exclusive license and development partnership. For more information, go to [ www.Lpath.com ].


Publication Contributing Sources

Similar Health and Fitness Publications